000 | 02095 a2200565 4500 | ||
---|---|---|---|
005 | 20250514183854.0 | ||
264 | 0 | _c20050124 | |
008 | 200501s 0 0 eng d | ||
022 | _a1107-3756 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTomita, Naruya | |
245 | 0 | 0 |
_aGene therapy with an E2F transcription factor decoy inhibits cell cycle progression in rat anti-Thy 1 glomerulonephritis. _h[electronic resource] |
260 |
_bInternational journal of molecular medicine _cMay 2004 |
||
300 |
_a629-36 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCDC2-CDC28 Kinases _xgenetics |
650 | 0 | 4 |
_aCell Cycle _xdrug effects |
650 | 0 | 4 |
_aCell Cycle Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aCell Nucleus _xmetabolism |
650 | 0 | 4 | _aCyclin-Dependent Kinase 2 |
650 | 0 | 4 |
_aDNA _xadministration & dosage |
650 | 0 | 4 |
_aDNA-Binding Proteins _xantagonists & inhibitors |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aDrug Carriers _xadministration & dosage |
650 | 0 | 4 | _aE2F Transcription Factors |
650 | 0 | 4 | _aGene Expression Regulation |
650 | 0 | 4 |
_aGenetic Therapy _xmethods |
650 | 0 | 4 |
_aGlomerulonephritis _xchemically induced |
650 | 0 | 4 |
_aIsoantibodies _ximmunology |
650 | 0 | 4 |
_aKidney _xcytology |
650 | 0 | 4 |
_aLiposomes _xadministration & dosage |
650 | 0 | 4 |
_aOligonucleotides _xadministration & dosage |
650 | 0 | 4 |
_aProliferating Cell Nuclear Antigen _xgenetics |
650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aSendai virus _xgenetics |
650 | 0 | 4 |
_aTranscription Factors _xantagonists & inhibitors |
700 | 1 | _aKim, John Y S | |
700 | 1 | _aGibbons, Gary H | |
700 | 1 | _aZhang, Lunan | |
700 | 1 | _aKaneda, Yasufumi | |
700 | 1 | _aStahl, Rolf A K | |
700 | 1 | _aOgborn, Malcom | |
700 | 1 | _aVenderville, Benoit | |
700 | 1 | _aMorishita, Ryuichi | |
700 | 1 | _aBaran, Dana | |
700 | 1 | _aDzau, Victro J | |
773 | 0 |
_tInternational journal of molecular medicine _gvol. 13 _gno. 5 _gp. 629-36 |
|
999 |
_c14782876 _d14782876 |